Status:
COMPLETED
Efficacy of FGM in Pregestational Diabetes
Lead Sponsor:
University of Catania
Conditions:
Diabetes Mellitus in Pregnancy
Eligibility:
FEMALE
18+ years
Brief Summary
Diabetes is the most common metabolic disease complicating pregnancy, and the number of women in childbearing age facing this problem is rising worldwide. The clinical and social significance of pre-g...
Detailed Description
Specific Aims Aim 1: To compare the glycemic control and glucose variability during pregnancy and at first postpartum visit in the two randomized groups. This was accomplished by the evaluation of the...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Pregnant women with pregestational diabetes
- HbA1c \>6.5%
- Exclusion Criteria
- Gestational Diabetes
- HbA1c \<6.5%
Exclusion
Key Trial Info
Start Date :
November 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 26 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04666818
Start Date
November 26 2020
End Date
November 26 2020
Last Update
December 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Catania, Endocrinology Section, Garibaldi-Nesima Hospital
Catania, Italy, 95122